Assessment of severity and frequency of self-reported hypoglycemia on quality of life in patients with type 2 diabetes treated with oral antihyperglycemic agents: A survey study
2011

Impact of Hypoglycemia on Quality of Life in Type 2 Diabetes Patients

Sample size: 1984 publication Evidence: high

Author Information

Author(s): Marrett Elizabeth, Radican Larry, Davies Michael J, Zhang Qiaoyi

Primary Institution: Global Health Outcomes, Merck Sharp & Dohme, Corp.

Hypothesis

The study aims to assess the impact of the severity and frequency of self-reported hypoglycemia on health-related quality of life among patients with type 2 diabetes treated with oral antihyperglycemic agents.

Conclusion

Self-reported hypoglycemia is independently associated with lower health-related quality of life, and the reduction in quality of life increases with both the severity and frequency of episodes.

Supporting Evidence

  • 63% of patients reported hypoglycemic episodes, with 46% mild, 37% moderate, 13% severe, and 4% very severe.
  • Mean utility score for patients reporting hypoglycemia was significantly lower (0.78) compared to those without (0.86).
  • Mean HFS score was significantly higher for patients reporting hypoglycemia (17.5) compared to those without (6.2).

Takeaway

If people with diabetes have low blood sugar too often, it can make them feel worse and worry more, which affects how happy they are with their life.

Methodology

A follow-up survey was conducted among participants with self-reported type 2 diabetes treated with oral antihyperglycemic agents, collecting data on hypoglycemic episodes and health-related quality of life using the EQ-5D and HFS.

Potential Biases

Potential bias due to the exclusion of individuals without internet access, which may affect the demographic representation.

Limitations

The study may have selection bias due to the internet-based survey method, and self-reported hypoglycemia may be subject to recall bias.

Participant Demographics

Mean age was 58 years, 57% male, 72% reported HbA1c <7.0%, and 50% reported treatment with a sulfonylurea-containing regimen.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1186/1756-0500-4-251

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication